Home/Filings/4/A/0001140361-10-046195
4/A//SEC Filing

Anderson Mark Brian 4/A

Accession 0001140361-10-046195

CIK 0001389545other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 1:48 PM ET

Size

6.1 KB

Accession

0001140361-10-046195

Insider Transaction Report

Form 4/AAmended
Period: 2010-11-15
Transactions
  • Award

    Option (right to buy)

    2010-11-15+40,000186,000 total
    Exercise: $1.89From: 2011-11-15Exp: 2020-11-14Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the exercise price from $1.85 to $1.89 per share.
  • [F2]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the grant date from November 12, 2010 to November 15, 2010.

Documents

1 file

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001474599

Filing Metadata

Form type
4/A
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 1:48 PM ET
Size
6.1 KB